Corporate titan turned London healthcare chief Sir Richard Sykes faces his toughest challenge yet, says Judi Bevan — but he’s full of praise for the handling of swine flu
Sir Richard Sykes darts across the hallway of the Athenaeum club to greet me. Lightly tanned, thin as a whippet, the former head of GlaxoSmithKline and Imperial College cuts a dash in pinstripes and a tie the colour of crushed raspberries.
Sykes is to ‘change czars’ what Roger Federer is to tennis. In both his former roles he radically changed the institutions he headed. Through the takeover of Wellcome, followed by merger with SmithKline Beecham, he transformed middleweight Glaxo into GlaxoSmithKline, the third largest pharmaceutical group in the world. As rector of Imperial, he dramatically improved standards and secured financial independence by floating Imperial Innovations. No wonder his old colleague, surgeon turned health minister Lord (Ara) Darzi, was so supportive when Sykes applied to be chairman of the newly created Strategic Health Authority for London.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in